Fellowship · Baltimore, MD
Sponsored by Johns Hopkins University School of Medicine
Long-term pulmonary outcomes in BPD throughout the life-course.
Journal of perinatology : official journal of the California Perinatal Association · 2026 · 25 citations · Michael Collaco
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
American journal of respiratory and critical care medicine · 2021 · 251 citations · Susanna McColley
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security.
The Lancet. Global health · 2025 · 55 citations · Eric McCollum
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele.
American journal of respiratory and critical care medicine · 2023 · 128 citations · Susanna McColley
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Hepatology (Baltimore, Md.) · 2024 · 74 citations · Shruti Phadke
Future therapies for cystic fibrosis.
Nature communications · 2023 · 117 citations · Marie Egan
Obesity-related asthma in children and adolescents.
The Lancet. Child & adolescent health · 2022 · 136 citations · Parisa Kaviany
Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
Pediatric pulmonology · 2021 · 158 citations · Susanna McColley